Study of BMS-986158 in Subjects With Select Advanced Cancers
NCT02419417
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
83
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Tumors
Interventions
DRUG:
BMS-986158
BIOLOGICAL:
Nivolumab
Sponsor
Bristol-Myers Squibb